Industry braced for new upheaval in primary care
September 8, 2005Sales and Marketing NHS, PCTs, Pfizer
Likely reductions in the number of PCTs could prove disruptive to pharmaceutical companies – but the development of another NHS …
Merck’s problems deepen as MHRA reveals investigation
September 8, 2005Sales and Marketing
The controversy around the withdrawal of Vioxx has taken a new twist with news its manufacturer is being investigated for …
Pfizer to select seven for preferred supplier list
September 8, 2005Medical Communications
Pfizer is to limit the number of healthcare agencies it works with in the UK, as it looks to streamline …
GSK acquires vaccines research and manufacturing facility
September 8, 2005Manufacturing and Production, Research and Development
GlaxoSmithKline has acquired a vaccines R&D and manufacturing facility in the US, which it will use to develop its next …
New RA drug from BMS gains recommendation
September 7, 2005Sales and Marketing
A new treatment for rheumatoid arthritis from Bristol-Myers Squibb has received recommendation approval from an FDA committee, bringing it one …
Advertising workshop
September 7, 2005Medical Communications
The investment risk in developing a profitable brand is huge and with every new brand launch comes escalating expectations. At …
The evolving world of advertising
September 6, 2005Medical Communications
The considerable challenges facing pharma companies over the past few years have taken centre stage in analysis of healthcare marketing: …
Junior doctors to be taught communication skills
September 6, 2005Newly qualified doctors will have to take a new training programme to teach them soft skills, such as how to …
Scientists back testing after guinea pig breeder forced to close
September 6, 2005Research and Development
UK scientists have rallied to support animal research after a six-year campaign against Staffordshire guinea pig breeder Darley Oaks Farm …
Pfizer demands action after more fake Lipitor found in UK
September 6, 2005Manufacturing and Production
The MHRA has discovered a second batch of counterfeit Lipitor in under a month, a worrying indication of a growing …
$1 billion Cialis closing on Viagra
September 6, 2005Sales and Marketing
Erectile dysfunction drug Cialis has achieved cumulative sales of $1 billion and is closing the gap on Pfizer's market leader …
All new product marketing to be pre-vetted in UK
September 2, 2005Medical Communications, Sales and Marketing
Advertising and marketing materials for all new products are to be vetted by the UK regulator for the accuracy of …
New NHS early warning system for long-term conditions
September 2, 2005A new computer program will give NHS clinicians an early warning about patients at risk of being admitted to hospital.The …
Takeda’s dependence-free sleeping pill approved
September 2, 2005Research and Development, Sales and Marketing
A new sleeping pill which patients cannot abuse or become dependent on has been approved in the US.Takeda's Rozerem (ramelteon) …
GP contract hailed as great success
September 2, 2005GPs in England have been hailed as world leaders in chronic disease management by the government following the release of …
Mixed news for Lilly’s neuropathy drug
August 23, 2005Lilly says it will file its new treatment for diabetic retinopathy with regulators by the end of the year – …
Schering’s new low-dose contraceptive approved in Netherlands
August 19, 2005Sales and Marketing
Yasminelle, a new low-dose oral contraceptive from Schering has received its first European marketing approval in the Netherlands. The country …
Recovery of healthcare PR highlights recruitment needs
August 18, 2005Medical Communications
The mood of optimism in healthcare PR is set to continue following an average 15% growth among agencies' net income …
Latest content
FibroFind appoints Lee Borthwick as CEO
